“Bimekizumab Provides Rapid and Sustained Improvements in Quality of Life That Correlate With Clinical Outcomes in Patients With Moderate to Severe Plaque Psoriasis: 60 Week Results from a Randomized , Double Blinded , Phase 2b Extension Study”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S35. Accessed May 18, 2025. https://skin.dermsquared.com/skin/article/view/762.